Press-release for stocks related to bioscience listed in the nasdaq exchange

| Email alert Add to watchlist
bioscience contraceptive grant technology funding development

Skye Bioscience to Present at Upcoming Investment Conferences
Published: 2024-04-23 (Crawled : 11:00) - globenewswire.com
SKYE | $14.81 -8.24% -8.98% 220K

| Email alert Add to watchlist
bioscience

Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Published: 2024-04-18 (Crawled : 19:00) - biospace.com/
TWST | $29.45 5.37% 5.22% 730K

| 3.08% | O: -0.04% H: 0.0% C: 0.0%
report bioscience financial results

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.2953 5.46% 4.5% 52K

| -37.32% | O: 1.36% H: 0.68% C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study

Skye Bioscience Uplists to The Nasdaq Global Market
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
SKYE | $14.81 -8.24% -8.98% 220K

| 61.5% | O: 6.87% H: 44.87% C: 30.71%
nasdaq bioscience global market

Harvard Bioscience Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth
Published: 2024-04-09 (Crawled : 13:00) - globenewswire.com
HBIO | $3.7 0.27% 91K

| -18.86% | O: -3.95% H: 6.16% C: 5.71%
investments bioscience ongoing growth

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 23:00) - biospace.com/
YTEN | $0.261 2.35% 4.49% 380K

| -31.58% | O: -0.42% H: 12.66% C: 1.24%
year bioscience financial results

Satellos Bioscience Announces 2023 Year End Financial Results and Operational Highlights
Published: 2024-03-27 (Crawled : 00:00) - biospace.com/
MSCLF | $0.3598 -3.02% 18.14% 15K

n/a

| 4.53% | O: 2.7% H: 1.41% C: 0.0%
year bioscience financial results

Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada
Published: 2024-03-26 (Crawled : 12:30) - globenewswire.com
YTEN | $0.261 2.35% 4.49% 380K

| -27.78% | O: -2.89% H: 2.95% C: -2.12%
cleared food bioscience canada

Daré Bioscience to Host Full Year 2023 Financial Results and Company Update Conference Call and Webcast on March 28, 2024
Published: 2024-03-21 (Crawled : 12:00) - globenewswire.com
DARE | $0.2953 5.46% 4.5% 52K

| -35.19% | O: 8.01% H: 0.0% C: -5.0%
conference company year bioscience update financial results

PURE Bioscience Reports Fiscal Second Quarter 2024 Financial Results
Published: 2024-03-18 (Crawled : 00:00) - biospace.com/
PURE | $0.08 19.4% 1.01% 74K

| -11.11% | O: 0.0% H: 0.0% C: -2.22%
bioscience financial results

Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)
Published: 2024-03-17 (Crawled : 12:20) - prnewswire.com
AADI | $1.9 3.26% 3.66% 160K

| Email alert Add to watchlist
origin bioscience advanced

Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate Update
Published: 2024-03-13 (Crawled : 14:30) - biospace.com/
AADI | $1.9 3.26% 3.66% 160K

| -2.06% | O: 0.0% H: 0.0% C: 0.0%
bioscience update financial results

Skye Bioscience Announces $40 Million Private Placement Equity Financing
Published: 2024-03-11 (Crawled : 19:00) - biospace.com/
SKYE | $14.81 -8.24% -8.98% 220K

| 11.14% | O: -1.31% H: 2.28% C: -23.95%
million bioscience

Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Published: 2024-03-07 (Crawled : 14:30) - biospace.com/
APVO | $0.71 -2.39% -3.77% 160K

| -88.91% | O: 19.53% H: 41.18% C: -13.73%
apv-527 alg.apv-527 positive bioscience tumor therapeutics study

Harvard Bioscience Announces Fourth Quarter 2023 Financial Results
Published: 2024-03-07 (Crawled : 12:00) - globenewswire.com
HBIO | $3.7 0.27% 91K

| -9.98% | O: -1.22% H: 13.42% C: 11.08%
bioscience financial results

Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate Update
Published: 2024-03-06 (Crawled : 17:00) - biospace.com/
AADI | $1.9 3.26% 3.66% 160K

| -9.95% | O: 0.47% H: 4.72% C: 2.83%
report bioscience update results

Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Published: 2024-03-06 (Crawled : 14:30) - biospace.com/
HBIO | $3.7 0.27% 91K

| -11.69% | O: 1.67% H: 3.48% C: -3.52%
bioscience preclinical solutions meeting

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Published: 2024-03-05 (Crawled : 15:30) - biospace.com/
TWST | $29.45 5.37% 5.22% 730K

| -22.99% | O: -1.15% H: 0.9% C: -2.67%
precision bioscience

Skye Bioscience Appoints Dr. Annalisa Jenkins to Board of Directors
Published: 2024-03-04 (Crawled : 12:00) - globenewswire.com
SKYE | $14.81 -8.24% -8.98% 220K